搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
1 天
Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate ...
About the Phase 3 DIAMOND Program of OCS-01 in Diabetic Macular Edema ...
3 天
Fighting ophthalmic disease that causes blindness
New AI-driven test identifies diabetic retinopathy risk, promising better care for patients in Israel and beyond.
optometryadvisor
4 天
Limited Eye Care Access Persists in Native American Communities
Native American eye care disparities limit access to care among a population disproportionately affected by ocular disease.
5 天
VRSI And RSSDI Launch First-Of-Its-Kind Diabetic Retinopathy Screening Guidelines To Save ...
With India being the diabetes capital of the world, the Vitreo Retinal Society of India (VRSI) and the Research Society for ...
5 天
Sei Investments Co. Acquires 30,683 Shares of Kodiak Sciences Inc. (NASDAQ:KOD)
Sei Investments Co. boosted its holdings in Kodiak Sciences Inc. (NASDAQ:KOD – Free Report) by 27.1% in the second quarter, ...
TMCnet
6 天
Opthea Wet AMD Program to be Presented at Innovate Retina
David Boyer, MD, will present an update on Opthea’s wet AMD program, including highlights of the unmet medical need in wet AMD, the sozinibercept Phase 2b trial results, and the Phase 3 program ...
MyChesCo on MSN
6 天
FDA Greenlights Ocugen’s Revolutionary Eye Treatment: What It Means for Vision Care
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced a pivotal development as the FDA lifted the clinical hold on ...
6 天
on MSN
Ocugen says FDA has removed clinical hold on eye drug OCU200
Ocugen (NASDAQ:OCGN) said the FDA has removed a clinical hold on its Investigational New Drug application for a Phase 1 study ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈